Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Contineum Therapeutics (CTNM)

Contineum Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CTNM
DateTimeSourceHeadlineSymbolCompany
04/06/202421:05Business WireContineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare ConferenceNASDAQ:CTNMContineum Therapeutics Inc
03/06/202422:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
03/06/202422:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
03/06/202421:05Business WireContineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate SecretaryNASDAQ:CTNMContineum Therapeutics Inc
31/05/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
29/05/202422:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
29/05/202422:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
29/05/202422:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
20/05/202421:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
20/05/202421:05Business WireContineum Therapeutics Announces Appointment of Troy Ignelzi to Board of DirectorsNASDAQ:CTNMContineum Therapeutics Inc
16/05/202422:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTNMContineum Therapeutics Inc
16/05/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
16/05/202421:05Business WireContineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CTNMContineum Therapeutics Inc
05/04/202402:02GlobeNewswire Inc.Contineum Therapeutics Announces Pricing of Initial Public OfferingNASDAQ:CTNMContineum Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTNM

Your Recent History

Delayed Upgrade Clock